Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). (Q43500577)
Jump to navigation
Jump to search
scientific article published on 5 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). |
scientific article published on 5 November 2015 |
Statements
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2) (English)
Phoebe Rich
Joana Goncalves
Robert M Day
Rongdean Chen
Jeffrey Crowley